Regulation of lipoprotein lipase mRNA content in 3T3-L1 cells by tumour necrosis factor. by Cornelius, Peter et al.
Biochem. J. (1988) 249, 765-769 (Printed in Great Britain)
Regulation of lipoprotein lipase mRNA content in 3T3-L1 cells
by tumour necrosis factor
Peter CORNELIUS,* Sven ENERBACK,t Gunnar BJURSELL,t Thomas OLIVECRONA: and
Phillip H. PEKALA*§
*Department of Biochemistry, East Carolina University School of Medicine, Greenville, NC 27858, U.S.A.,
tDepartment of Physiological Chemistry, University of Gothenburg, S-413 46 Gothenburg, Sweden, and$Department of Physiological Chemistry, University of Umea, S-90187 Umea, Sweden
Tumour necrosis factor (TNF) was previously shown to suppress lipoprotein lipase (LPL) synthesis and
activity in 3T3-L1 adipocytes. The present study examined the effect ofTNF on amounts ofmRNA for LPL
in 3T3-Ll cells. Northern-blot analysis of polyadenylated RNA using a cDNA probe to guinea-pig LPL
identified two predominant species of LPL message, 3.7 and 3.9 kilobases in size. The steady-state amounts
of these mRNAs increased 10-fold upon expression of the adipocyte phenotype. A single dose of 1.5 nM-
TNF decreased LPL mRNA by approx. 60% in 17 h with a corresponding decrease in LPL activity, an
effect that was reversed 48 h after exposure to TNF. The results demonstrate that TNF reversibly down-
regulates LPL mRNA in fully differentiated 3T3-Ll adipocytes. Cells induced to differentiate in the presence
of 1.5 nM-TNF exhibited a delayed time course for development of the adipocyte phenotype, as judged by
attenuation of the normal increase in LPL mRNA that occurs with differentiation.
INTRODUCTION
Lipoprotein lipase (LPL) catalyses the hydrolysis of
lipoprotein-derived triacylglycerol, providing fatty acids
for storage or catabolism in specific mammalian tissues.
Its activity in adipose tissue allows the accumulation of
fatty acids, which are re-esterified in adipocytes to form
stored triacylglycerol. The enzyme is subject to potent
regulation by both nutritional and hormonal signals,
with marked loss of the adipose-tissue enzyme activity
occurring upon fasting (Semb & Olivecrona, 1986).
Diminished LPL activity in various disease states, such
as chronic infections and malignancies, leads to de-
rangements in lipid metabolism, resulting in severe
hypertriglyceridaemia (Marclay et al., 1967; Brenneman
et al., 1975; Kaufmann et al., 1976; Rouzer & Cerami,
1980). Moreover, in many of these studies an overall
catabolic state was observed. Regulation of the onset of
this catabolic state, as well as the suppression of LPL
activity, have been attributed to a group of proteins
known collectively as monokines, which are secretory
proteins from the phagocytic cells of the immune system
(Bagby & Spitzer, 1980; Kawakami & Cerami, 1981;
Kurzrock et al., 1986; Beutler & Cerami, 1986a; Nathan,
1987). These proteins, interacting with specific plasma-
membrane receptors on target tissues, regulate diverse
metabolic pathways. In adipocytes, three monokines, i.e.
tumour necrosis factor (TNF), interleukin- 1 and y-
interferon, have been shown to attenuate the activity of
LPL (Beutler et al., 1985; Price et al., 1986a,b; Beutler &
Cerami, 1986b; Patton et al., 1986). Price et al. (1986a,b,c)
have demonstrated that at least TNF and interleukin- 1
suppress LPL activity in 3T3-L1 adipocytes by inhibiting
the synthesis of the enzyme. This conclusion was based
on data demonstrating that, after the cells were incubated
with either monokine, the incorporation of [35S]-
methionine into immunoprecipitable LPL was in-
hibited. In addition, these monokines had no effect on
the half-life ofLPL activity. Lipoprotein lipase is a short-
lived enzyme; half-lives of approx. 30 min have been
reported (Robinson, 1970; Wise & Green, 1978; Vannier
et al., 1985; Amri et al., 1986; Semb & Olivecrona, 1986;
Olivecrona et al., 1987). Although there has been no
direct information on the turnover of LPL mRNA, the
rapid decrease ofLPL synthesis in the 3T3-LI adipocytes
exposed to TNF, coupled with the short half-life for
enzyme activity, suggests that the mRNA is rapidly
turned over. Thus TNF regulation of LPL synthesis may
occur at the level of monokine-induced alterations in
LPL mRNA content, secondary to decreased gene
activity or mRNA stability.
The availability of a cDNA probe (Enerback et al.,
1987) presented an opportunity to test directly whether
TNF down-regulation of LPL mRNA is involved in
regulation of the enzyme's activity. Using 3T3-LI cells,
we have examined the effect of TNF on LPL mRNA
amounts and LPL enzyme activity, in order to define the
step at which TNF inhibits LPL synthesis.
EXPERIMENTAL
Miscellaneous techniques
3T3-LI preadipocytes obtained from Dr. Howard
Green, Harvard University, Boston, MA, U.S.A., were
cultured and induced to differentiate as previously
described by Price et al. (1986b). Exposure of the cells to
TNF was carried out by the protocol described by Price
et al. (1986b) unless otherwise noted. LPL activity
associated with the heparin-releasable fraction of the
monolayers was determined by the method ofKawakami
et al. (1982). Enzyme activity is reported in munits,
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defined as nmol of fatty acid released/min. Although we
realize the limitations of determining the activity of the
lipase with a heparin-releasable fraction, our previous
studies have demonstrated that the activity in this fraction
is the most sensitive assay for TNF and accurately
reflects whole-cell lipase activity (Kawakami et al., 1982).
Results of these enzyme assays are summarized as
means+ S.D. All assays were performed in triplicate.
Protein values were determined by the method of
Bradford (1976).
RNA isolation
Total RNA was isolated from cells by extraction with
guanidine isothiocyanate and centrifugation through
5.7 M-CsCl as described by Chirgwin et al. (1979).
Poly(A)+ RNA was isolated from total RNA by using
oligo(dT)-cellulose as per the manufacturer's instruc-
tions.
RNA analysis
For Northern analysis, 20,ug of total RNA or 4 ug of
poly(A)+ RNA was separated by electrophoresis in 0.8%
or 1.1 % agarose/2.0 M-formaldehyde gels and trans-
ferred to NitroPlus 2000, as described by Maniatis et al.
(1982). After baking for 2 h at 80 IC in a vacuum oven,
filters were prehybridized at 46 °C for 4 h in 50% (v/v)
formamide containing 5 x SSPE (0.9 M-NaCl/0.05 M-
NaH2PO4/5 mM-EDTA, pH 7.4), 0.2% SDS, 0.1 % each
of bovine serum albumin, polyvinylpyrrolidone and
Ficoll, and 200 ,ug of yeast tRNA/ml. Hybridizations
were carried out overnight under the same conditions in
the presence of 1 x 107 c.p.m. of a nick-translated LPL
cDNA probe (Enerback et al., 1987)/ml and 3.0 x 106
c.p.m. of a nick-translated cDNA probe to chicken /,-
actin (Cleveland et al., 1980)/ml. The LPL cDNA probe
was a 2.2 kb fragment containing the C-terminal half of
the coding sequence for guinea-pig LPL and 1.55 kb of
the 3'-untranslated region. After hybridization, filters
were washed in 0.1 x SSPE/0.1 % SDS for approx. 2 h at
64°C with constant agitation and then subjected to
autoradiography by using Kodak XAR-5 film for various
times at -80°C to ensure linear film response. The
relative intensity of bands on the autoradiograph was
quantified with a Biomedical Instruments (Fullerton,
CA, U.S.A.) laser densitometer equipped with a peak
integrator. The RNA slot-blot analysis was carried out
with 5 ,ug of total RNA which was denatured by heating
for 10 min at 65 °C in 4% formaldehyde and then
applied to NitroPlus 2000 with a Bethesda Research
Laboratories Hybri-Slot Manifold. After baking for 2 h
at 80 °C in a vacuum oven, the slot-blot was probed with
nick-translated LPL-cDNA probe as described above.
Materials
Recombinant murine TNF was generously given by
Biogen (Cambridge, MA, U.S.A.). The specific activity
was 9.6 x 106 units/mg ofprotein, based on a cytotoxicity
assay using L929 cells. The endotoxin contamination
was 0.12 ng/mg ofprotein, based on a Limulus amaebocyte
lysate assay. The chicken /3-actin cDNA probe was
obtained from Dr. Don W. Cleveland, Johns Hopkins
University. A nick-translation kit was purchased from
Bethesda Research Laboratories. [32P]dCTP (800 Ci/
mmol) and [3H]triolein were purchased from New
England Nuclear. NitroPlus 2000 (nitrocellulose) was
purchased from Fisher. Oligo(dT)-cellulose was ob-
tained from Collaborative Research.
RESULTS
Molecular size of LPL mRNA in the 3T3-L1 cells
The molecular size of mRNA coding for LPL was
determined by using RNA isolated from both undifferen-
tiated and fully differentiated 3T3-L1 cells as well as
from mouse heart; 20,g of total RNA or 4,ug of
poly(A)+RNA from each cell type or tissue was used for
Northern analysis with nick-translated LPL-cDNA
probe as described in the Experimental section. After
autoradiography, it was possible to identify two major
species of LPL mRNA in 3T3-L1 cells (Fig. 1, lanes a, b
and d). For comparison, mRNA from mouse heart was
also analysed (Fig. 1, lanes c and e). Previous work by
Kirchgessner et al. (1987) had demonstrated the presence
of two major species of mRNA for LPL in a variety of
mouse tissues. Our results support the observation that
two forms of LPL mRNA predominate in mouse heart,
and these species appear identical with that found in the
3T3-L1 cells (Fig. 1). The molecular size of these mRNA
species as determined by using calibrated RNA standards
was 3.7 and 3.9 kb. The two different LPL mRNAs were
most readily observed when poly(A)+ RNA was analysed
after separation on a 1.1 %-agarose gel (Fig. 1, lanes d
and e). Minor species of LPL mRNA (1.7 and 2.7 kb in
the 3T3-L1 cells and 1.7 kb in the heart) were observed
after prolonged autoradiography (results not shown).
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Fig. 1. Molecular size of LPL mRNA in 3T3-Ll cells
Total RNA and poly(A)+ RNA were isolated from 3T3-Ll
cells and from mouse heart, and examined by Northern
analysis as described in the Experimental section. Samples
were 20 ,sg of total RNA from confluent undifferentiated
3T3-Ll fibroblasts (lane a), fully differentiated 3T3-Ll
adipocytes (lane b), and mouse heart (lane c), or 4 ,ig of
poly(A)+ RNA from fully differentiated adipocytes (lane d)
and mouse heart (lane e). The results displayed are
representative of an experiment performed twice with
different preparations of RNA [total and poly(A)+], with
identical results.
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Fig. 2. Differential expression and TNF regulation of LPL
mRNA in 3T3-L1 cells
Total RNA was isolated from 3T3-L1 cells at various
times and 20 cg samples were examined by Northern
analysis as described in the Experimental section. Lane (a),
confluent undifferentiated fibroblasts; lane (b), fully
differentiated adipocytes; lane (c), adipocytes treated for
17 h with 1.5 nM-TNF (250 units/ml); lane (d), adipocytes
48 h after TNF addition; lane (e), cells induced to
differentiate in the presence of 1.5 nM-TNF, with RNA
isolated 6 days later. The autoradiogram displayed is
representative of an experiment performed twice with
different preparations of RNA, with identical results.
As demonstrated in Fig. 1 (lane a), confluent undif-
ferentiated 3T3-L1 cells contain a measurable quantity
of LPL mRNA, although in these same cells enzyme
activity is barely detectable ( < 0.1 munit/mg of protein).
The amount of LPL mRNA increased 10-fold, as
determined by densitometric analysis, upon adipocyte
conversion (Fig. 1, lane b). This corresponded to an
increase in enzyme activity to 48+4 munits/mg of
protein.
Effects of TNF on amounts of LPL mRNA
In order to characterize the effect of TNF on amounts
of mRNA coding for LPL, total RNA was prepared
from 3T3-L1 cells of the same passage, plated at the
same time. Undifferentiated and fully differentiated cells,
and cells exposed to 1.5 nM-TNF, were included in the
following experiment. From each preparation 20 ,g of
RNA was used for Northern analysis as described in the
Experimental section. In this experiment the 10-fold
increase of LPL mRNA upon differentiation was again
observed (Fig. 2, lanes a and b), with an increase in LPL
activity to 33+1.3 munits/mg of protein. After these
fully differentiated cells were exposed to 1.5 nM-TNF for
17 h (Fig. 2, lane c), the amount of LPL mRNA
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Fig. 3. Suppression of LPL mRNA by TNF
Total RNA was extracted from fully differentiated 3T3-Ll
adipocytes at various times after exposure to 1.5 nM-TNF
(250 units/ml), and 5 ,ug samples were subjected to slot-
blot analysis as described in the Experimental section.
Inset shows (a) control adipocytes, and adipocytes (b) 3 h,
(c) 6 h and (d) 17 h after TNF. The main Figure shows
densitometric analysis of the autoradiogram in the inset.
The data displayed are representative of an experiment
performed twice with identical results.
decreased by nearly 60 %, and activity was depressed to
approx. 8 + 0.4 munits/mg of protein, a decrease of 76%.
However, after 48 h of continuous exposure to TNF
(Fig. 2, lane d), LPL.mRNA content and enzyme activity
approached the values seen in control fully differentiated
cells (mRNA, 85 % of control; enzyme activity, 25 + 0.6
munits/mg of protein, 77% of control). Thus the effects
were reversed in the continued presence of TNF. As a
control for these determinations, the amounts of fl-actin
mRNA were also measured. Amounts of ,-actin mRNA
have previously been shown to decrease by 50% upon
differentiation (Bernlohr et al., 1985), and lanes (a) and
(b) of Fig. 2 confirm those findings. A 12 % decrease in
,fl-actin mRNA is observed after 17 h of exposure to
1.5 nM-TNF (lane c), with amounts returning to normal
at 48 h (lane d). Lane (e) is an analysis ofmRNA isolated
from 3T3-L1 cells induced to differentiate in the presence
of TNF. That is, at 2 days post confluence, the cells were
treated with 0.5 mM-isobutylmethylxanthine, 1 /tM-dexa-
methasone and 10 ,ug of insulin/ml to induce differentia-
tion, while at the same time the medium was made 1.5 nm
in TNF. The medium was then replaced every 48 h with
fresh medium supplemented only with 2.5 jug of insulin/
ml for the first two feedings, with insulin omitted for the
final feeding. At 6 days after removal of isobutylmethyl-
xanthine and dexamethasone (the same age and treatment
as with cells used for analysis in lanes b and c), RNA was
isolated and analysed as described above. The results
(lane e) indicate that this single exposure to TNF was
sufficient to prevent full expression of LPL mRNA (only
35 % of fully differentiated; lane b) and to prevent the
full attenuation of the ,-actin mRNA. LPL activity also
remained low, at 15+0.6 munits/mg of protein (45 %
that of fully differentiated cells).
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Our previous work demonstrated that exposure of the
fully differentiated 3T3-L1 cells to TNF resulted in a
rapid suppression of both activity and synthesis of LPL
(Price et al., 1986b,c), with maximal suppression occur-
ring between 12 and 17 h after addition of the monokine.
To determine if the observed decreases in activity and
synthesis mirrored a decrease in LPL mRNA content,
total RNA was isolated from fully differentiated 3T3-Ll
cells throughout a 17 h time course of exposure to TNF.
By using a slot-blot technique, 5 ,g of total RNA from
each time point was applied to nitrocellulose, hybridized
to nick-translated LPL cDNA probe, and the degree of
hybridization was quantified by densitometry as de-
scribed in the Experimental section. The results demon-
strate that, relative to LPL mRNA isolated from fully
differentiated untreated control cells (Fig. 3, inset, lane
a), LPL mRNA decreases after TNF addition, by 20%
after 3 h (lane b), 40% after 6 h (lane c), and 85% after
17 h (lane d). The activity of LPL, measured throughout
the time course of exposure to TNF, was also suppressed
(54.9+2.9, 16.3+0.4, 6.6+1.2, 2.7+0.9 munits/mg of
protein for control and at 3, 6 and 17 h respectively). In
additional experiments, the amount of LPL mRNA had
begun to increase 24 h after addition ofTNF. Moreover,
no selectivity was observed with respect to either species
ofmRNA (3.7 or 3.9 kb) that were suppressed after TNF
treatment (P. Cornelius & P. H. Pekala, unpublished
work).
DISCUSSION
Our results demonstrate that 3T3-L1 cells express
multiple species of mRNA coding for LPL. Similar
results were obtained by Enerback et al. (1987) working
with guinea-pig adipocytes, where three major (3.8, 3.3
and 2.1 kb) and one minor (4.5 kb) species of LPL
mRNA were detected. Wion et al. (1987) have also
detected two LPL mRNA species, of 3.3 and 3.8 kb, in
human adiposse tissue, and Kirchgessner et al. (1987)
observed mRNA species of 3.4 and 3.6 kb in both mouse
adipose and heart tissue, with an additional 1.7 kb
species in the heart. Furthermore, Senda et al. (1987), on
analysis of bovine mammary-gland LPL mRNA, ob-
served species of 3.2, 2.7 and 1.7 kb. These differences
have been attributed to the presence of multiple
polyadenylation signals (Kirchgessner et al., 1987). In
the present study, the distribution patterns of both
mouse heart and 3T3-L1 LPL mRNA were identical with
those obtained by Kirchgessner et al. (1987). However,
minor differences in molecular size were observed; the
sources of these variations are unknown. We note that
estimations of molecular size were derived from cali-
brated RNA standards that exhibited linearity [mobility
versus log (molecular size)] over a range of 4.5-1.4kb.
Our data further indicate that LPL mRNA is available
for hybridization in confluent undifferentiated cells,
which synthesize barely detectable amounts of LPL
protein (Olivecrona et al., 1987). Densitometric measure-
ments from Northern analysis (Figs. 1 and 2) indicate
that LPL mRNA increases approx. 10-fold as the cells
differentiate and mature into adipocytes, whereas
enzyme activity increases at least 100-fold (Wise &
Green, 1978; Olivecrona et al., 1987). As a control for
this measurement, the amounts of 8-actin mRNA were
also measured. This mRNA has previously been shown
to decrease by approx. 50% as the 3T3-L1 cells
differentiate into adipocytes (Bernlohr et al., 1985). The
observation of the expected decrease in ,-actin mRNA
suggests that the increase observed in LPL mRNA is a
specific result of the differentiation process.
Exposure of the cells to TNF resulted in a significant
loss of both LPL activity (80% decrease) and LPL
mRNA amounts (60% decrease, Fig. 2), evidence that
the molecular basis for the loss of LPL activity is a
significant decrease in LPL mRNA available for trans-
lation. A minor decrease (12%) was also observed in
amounts of mRNA for ,J-actin, suggesting that a small
percentage of the decrease in LPL mRNA may be due to
a general, although minor, suppression of transcription.
In the subsequent experiment (Fig. 3), the time course for
loss of hybridizable LPL mRNA followed the loss of
enzyme activity. Again, as amounts of LPL mRNA
decreased, LPL activity was suppressed. We note that in
this study (Fig. 3) LPL mRNA decreased by 85 %,
compared with the 60% decrease observed in the
previous experiment (Fig. 2), whereas enzyme activity
declined by nearly 95 %, compared with the 80%
suppression previously demonstrated. The difference can
be explained by the minor variation in response to TNF
observed with respect to passage of the 3T3-L1 cells. A
15% variation has been observed and documented
previously (Beutler et al., 1985). The observation that
amounts of LPL mRNA returned to 85% of control
after a single, continuous, exposure to TNF (Fig. 2)
provides further support that the monokine is a potent,
but reversible, regulator of adipose-tissue metabolism.
Studies of the effects ofTNF in vivo on LPL in guinea
pigs have demonstrated a 20% decrease in adipose-tissue
LPL mRNA coupled with a 46 % decrease in LPL
activity 16 h after TNF treatment (30,g, intraperitone-
ally) (S. Enerback, unpublished results). This lends
further support to the hypothesis that TNF regulates
LPL activity by suppressing amounts ofmRNA available
for translation. Dobson et al. (1987) have demonstrated
that TNF down-regulates the activity of glycerophos-
phate dehydrogenase by suppressing the mRNA for this
enzyme in F442-A cells (an adipogenic clone of 3T3 cells
related to the 3T3-L1 cells), indicating that control of
mRNA amounts may be a generalized mechanism of
TNF action.
It has been suggested that both crude and recombinant
preparations of TNF block differentiation of preadipo-
cytes to adipocytes (Torti et al., 1985). In the present
study, however, evidence is provided that a single dose of
TNF added at the induction of differentiation of 3T3-L1
cells did not stop the differentiation process in its entirety
(Fig. 2, lane e). LPL mRNA had nearly doubled,
whereas fl-actin mRNA decreased significantly. More-
over, the cells had begun to accumulate lipid (- 20%
relative to control; P. Cornelius & P. H. Pekala, unpub-
lished work), indicating that these cells began the
transition, although somewhat delayed, to adiposity.
The results may differ upon exposure of the cells to
multiple doses of the monokine; this requires investi-
gation, together with the effects of this monokine on the
transcriptional process.
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